General Announcement::Lonza Announces Agreement to Manufacture AstraZeneca's COVID-19 Long-Acting Antibody Combination

Issuer & Securities

Issuer/ Manager
LONZA GROUP LTD
Securities
LONZA GROUP LTD - CH0013841017 - O6Z
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Oct-2020 14:00:34
Status
New
Announcement Sub Title
Lonza Announces Agreement to Manufacture AstraZeneca's COVID-19 Long-Acting Antibody Combination
Announcement Reference
SG201030OTHRUICW
Submitted By (Co./ Ind. Name)
Esther Au
Designation
SGXNet Authorised User
Effective Date and Time of the event
30/10/2020 14:00:00
Description (Please provide a detailed description of the event in the box below)
Please see attached news release.

Attachments